From: GENESISS 2—Generating Standards for In-Situ Simulation project: a systematic mapping review
Confidence scores | |||
Davison 2017 [98] 1 × ISS (n = 89) Study specific questionnaire | Pre Mean Scores (SD) | Post Mean Scores (SD) | Significance |
28.8 (6.3) | 30.8 (4.6) | < 0.001 | |
Allan 2010 [111] 1 × ISS (n = 182) Study specific questionnaire | Pre v Post | < 0.001 | |
Lavelle 2017 [2] Regular weekly ISS (n = 53) Study specific questionnaire | 3.6 (0.9) | 4.1 (0.9) | < 0.001 |
Nickerson 2019 [113] 1 × 15 min ISS (n = 23) Study specific questionnaire | 1.4 | 2.8 | NR |
Saqe-Rockoff 2019 [96] 1 × ISS (n = 43) C-Scale (Grundy 1993) | 2.5 (0.8) | 3.9 (0.6) | < 0.001 |
Surcouf 2013 [114] 1 × ISS (n = 27) Study specific questionnaire | 2.53 (0.46) | 2.92 (0.56) | < 0.001 |
Van Schaik 2011 [103] Regular interprofessional team training (monthly – quarterly) Study specific questionnaire | Basic PGY 1/2/3 3.59 (0.56) 4.08 (0.44) 4.12 (0.5) Advanced PGY1/2/3 2.35 (0.6) 2.81 (0.6) 2.71 (0.52) Expert PGY1/2/3 1.5 (0.76) 1.73 (0.82) 1.44 (0.57) Leadership PGY1/2/3 1.88 (0.79) 2.77 (0.62) 3.06 (0.91) | Basic PGY 1/2/3 3.73 (0.6) 3.97 (0.44) 4.36 (0.37) Advanced PGY1/2/3 2.52 (0.67) 2.68 (0.6) 3.17 (0.51) Expert PGY1/2/3 1.75 (0.71) 1.54 (0.8) 1.95 (0.84) Leadership PGY1/2/3 2.32 (0.88) 2.84 (0.61) 3.57 (0.62) | 0.301 0.110 0.156 0.011 |
Dowson 2013 [112] IG 3 × ISS (n = 20) Clinical Confidence Rating Scale [108] | Month 1 CG 57.8 (10.7) Month 1 IG 47.3 (6.68) | Month 3 CG 60 (10) Month 3 IG 56.6 (7) | NS < 0.001 |
Nunnink 2009 [117] 3 × ISS and 2 × video training (n = 49) Study specific questionnaire | ISS 9 (4.3) Video 11.2 (3.8) | ISS 12.9 (3.6) Video 12.4 (4.1) | 0.001 0.03 |
Performance scores | |||
Gardner 2013 [71] 1 × ISS Study specific questionnaire | 3.72 (0.53) | 3.52 (0.7) | < 0.001 |
Nickerson 2019 [113] 1 × ISS 15 min (n = 23) Study specific questionnaire | 67% 62% | 86% 89% | Not reported |
Saqe-Rockoff 2019 [96] 1 × ISS (n = 43) Clinical Performance Tool (Donoghue et al. 2010) | 5.3 (0.9) | 9.2 (0.6) | 0.004 |
Boyde 2018 [104] 1 × ISS (n = 50) Self-Efficacy in Clinical Performance scale (Munroe et al., 2015) | 165.15 (28.1) | 214.12 (26) | < 0.001 |
Rubio-Gurung 2014 [24] IG 1 × 4-h ISS training session (n = 120) Team Emergency Assessment Measure (TEAM) (Cooper et al. 2010) | CG post Median 6.7 (3.4–8.3) | IG post Median 19.9 (13.3–25) | 0.001 |
Kurosawa 2014 [108] 6 × ISS (n = 40) Validated Clinical Performance Tool | CG post 14.9 (4.4) | IG post 22.4 (3.9) | 0.001 |
Management and leadership scores | |||
Allan 2010 [111] 1 × ISS (one component of improvement project) (n = 182) Study specific questionnaire | NR | NR | < 0.001 |
Dowson 2013 [112] IG 3 × ISS training (n = 20) Clinical Confidence Rating Scale | Month 1 CG 2.9 (0.57) Month 1 IG 2.2 (0.42) | Month 3 CG 2 (0.7) Month 3 IG 2.8 (0.4) | NS < 0.05 |
Communication scores | |||
Gardner 2013 [71] at least1 x ISS Questionnaire developed by O’Neill et al. (1994) | 3.64 (0.64) | 3.82 (0.6) | < 0.05 |
Villemure 2019 [118] IG 6 h training: including 3 × ISS scenarios 30 min each Work Collaborative Questionnaire (Chiocchio et al. 2012) | CG 5.27 (0.95) IG 4.9 (0.91) | NS | |
Anxiety scores | |||
Allan 2010 [111] 1 × ISS as one component of improvement project (n = 182) Study specific questionnaire | Pre / Post | < 0.001 | |
Boyde 2018 [104] 1 × ISS (n = 50) State-Trait Anxiety Inventory (STAI) Anxiety State (Spielberger et al. 1983) | 38.56 (9.87) | 33.54 (9) | < 0.001 |
Knowledge scores | |||
Crofts 2007 [115] Single ISS (comparing in situ n = 64, with simulation centre training n = 69, without and without teamwork training) Study specific questionnaire | In situ pre 81.5 (21.3) Simulation centre pre 79.4 (22.1) | In situ post 101.5 (21.5) Simulation centre post 100.5 (21.1) | NS difference between ISS and sim centre |
Lavelle 2017 [2] Regular weekly ISS (n = 53) Study specific questionnaire | 38.6 (19.3) | 53 (16) | < 0.001 |
Nickerson 2019 [113] 1 × 15 min ISS Study specific questionnaire | 57% | 72% | Not reported |
Patterson 2013b [101] 2 day education intervention with ISS (n = 289), re-evaluation at 10 months (n-151) Study specific questionnaire | 86% (SD 9.8%) | 96% (SD 5.8%) Re-evaluation 93% (SD 7.3%) | < 0.001 |